New research indicates that individuals who come off new slimming jabs like Mounjaro or Wegovy tend to recover reduced body mass at a significantly accelerated pace than those who halt traditional diet and exercise regimens.
Research printed in a major medical journal demonstrates that while overweight individuals often shed about a fifth of their total mass while using the jabs, the weight is regained at an estimated rate of nearly a kilo each month upon discontinuation.
"Users purchasing these drugs need to be informed of the danger of rapid rebound weight gain when the treatment ends," stated expert Dr. Susan Jebb.
That rate of recovery implies a reversion to starting weight in about one and a half years.
Analyzing Approaches
The analysis, which examined 37 of trials involving thousands of patients, compared the outcomes of GLP-1 agonists with conventional dieting.
The team emphasize that individuals who lose weight through diet and exercise typically have a less rapid weight regain—around 0.1 kg a month—after stopping.
Understanding the Fast Regain
Nutrition scientists suggest the mechanism of the drugs is key to understanding the accelerated weight return.
These medications imitate a body's own chemical called glucagon-like peptide-1, which controls hunger.
"Sustained high doses of the hormone levels several times higher than the body's typical production could lead to the body to produce less of its endogenous GLP-1, and could lessen responsiveness to its effects," said Dr. Adam Collins, a dietetics researcher.
"Stopping of this hormone supplement results in appetite is unsuppressed, making overeating far more likely."
A Lifelong Condition?
Medical guidelines suggest the injections for individuals with weight-linked medical conditions, accompanied by recommended diet and exercise modifications.
A number of clinicians say that, given the likelihood of weight regain, the therapy is often life-long.
This perspective is echoed by pharmaceutical companies, who note that the findings "underscore the persistent character of excess weight," similar to managing diseases like high blood pressure.
User Experiences
People who have come off the medication report a powerful resurgence of hunger.
"It was like a trigger activating and I was suddenly ravenous," said a patient.
The struggle is exacerbated if users have not adopted sustainable lifestyle or habit modifications during treatment.
Significant Adoption
Figures suggest that millions of people in the UK have tried these injections in the last 12 months, with desire continuing to grow.
- Adoption is greater among women compared to men.
- The middle-aged age group shows the highest level of interest.
- Many obtain the drugs through private healthcare rather than the NHS.
Ultimately, researchers stress that while GLP-1 drugs are effective agents for shedding pounds, they are not a standalone solution and long-term success likely depends on integrated lifestyle support.
